49 results on '"Philippe, Bergeron"'
Search Results
2. Cryo-EM reveals an unprecedented binding site for NaV1.7 inhibitors enabling rational design of potent hybrid inhibitors
- Author
-
Marc Kschonsak, Christine C Jao, Christopher P Arthur, Alexis L Rohou, Philippe Bergeron, Daniel F Ortwine, Steven J McKerrall, David H Hackos, Lunbin Deng, Jun Chen, Tianbo Li, Peter S Dragovich, Matthew Volgraf, Matthew R Wright, Jian Payandeh, Claudio Ciferri, and John C Tellis
- Subjects
Nav 1.7 ,sodium channel ,pain ,drug discovery ,cryo-EM ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
The voltage-gated sodium (NaV) channel NaV1.7 has been identified as a potential novel analgesic target due to its involvement in human pain syndromes. However, clinically available NaV channel-blocking drugs are not selective among the nine NaV channel subtypes, NaV1.1–NaV1.9. Moreover, the two currently known classes of NaV1.7 subtype-selective inhibitors (aryl- and acylsulfonamides) have undesirable characteristics that may limit their development. To this point understanding of the structure–activity relationships of the acylsulfonamide class of NaV1.7 inhibitors, exemplified by the clinical development candidate GDC-0310, has been based solely on a single co-crystal structure of an arylsulfonamide inhibitor bound to voltage-sensing domain 4 (VSD4). To advance inhibitor design targeting the NaV1.7 channel, we pursued high-resolution ligand-bound NaV1.7-VSD4 structures using cryogenic electron microscopy (cryo-EM). Here, we report that GDC-0310 engages the NaV1.7-VSD4 through an unexpected binding mode orthogonal to the arylsulfonamide inhibitor class binding pose, which identifies a previously unknown ligand binding site in NaV channels. This finding enabled the design of a novel hybrid inhibitor series that bridges the aryl- and acylsulfonamide binding pockets and allows for the generation of molecules with substantially differentiated structures and properties. Overall, our study highlights the power of cryo-EM methods to pursue challenging drug targets using iterative and high-resolution structure-guided inhibitor design. This work also underscores an important role of the membrane bilayer in the optimization of selective NaV channel modulators targeting VSD4.
- Published
- 2023
- Full Text
- View/download PDF
3. Author response: Cryo-EM reveals an unprecedented binding site for NaV1.7 inhibitors enabling rational design of potent hybrid inhibitors
- Author
-
Christine C Jao, Marc Kschonsak, Christopher P Arthur, Alexis L Rohou, Philippe Bergeron, Daniel F Ortwine, Steven J McKerrall, David H Hackos, Lunbin Deng, Jun Chen, Tianbo Li, Peter S Dragovich, Matthew Volgraf, Matthew R Wright, Jian Payandeh, Claudio Ciferri, and John C Tellis
- Published
- 2023
- Full Text
- View/download PDF
4. An integrated suite of modeling tools that empower scientists in structure- and property-based drug design.
- Author
-
Jianwen A. Feng, Ignacio Aliagas, Philippe Bergeron 0002, Jeffrey M. Blaney, Erin K. Bradley, Michael F. T. Koehler, Man-Ling Lee, Daniel F. Ortwine, Vickie Tsui, Johnny Wu, and Alberto Gobbi
- Published
- 2015
- Full Text
- View/download PDF
5. A Cell-Signaling Network Temporally Resolves Specific versus Promiscuous Phosphorylation
- Author
-
Evgeny Kanshin, Louis-Philippe Bergeron-Sandoval, S. Sinan Isik, Pierre Thibault, and Stephen W. Michnick
- Subjects
Biology (General) ,QH301-705.5 - Abstract
If specific and functional kinase- or phosphatase-substrate interactions are optimized for binding compared to promiscuous interactions, then changes in phosphorylation should occur faster on functional versus promiscuous substrates. To test this hypothesis, we designed a high temporal resolution global phosphoproteomics protocol to study the high-osmolarity glycerol (HOG) response in the budding yeast Saccharomyces cerevisiae. The method provides accurate, stimulus-specific measurement of phosphoproteome changes, quantitative analysis of phosphodynamics at sub-minute temporal resolution, and detection of more phosphosites. Rates of evolution of dynamic phosphosites were comparable to those of known functional phosphosites and significantly lower than static or longer-time-frame dynamic phosphosites. Kinetic profile analyses indicated that putatively functional kinase- or phosphatase-substrate interactions occur more rapidly, within 60 s, than promiscuous interactions. Finally, we report many changes in phosphorylation of proteins implicated in cytoskeletal and mitotic spindle dynamics that may underlie regulation of cell cycle and morphogenesis.
- Published
- 2015
- Full Text
- View/download PDF
6. CryoEM reveals unprecedented binding site for NaV1.7 inhibitors enabling rational design of potent hybrid inhibitors
- Author
-
Marc Kschonsak, Christine C. Jao, Christopher P. Arthur, Alexis L. Rohou, Philippe Bergeron, Daniel Ortwine, Steven J. McKerrall, David H. Hackos, Lunbin Deng, Jun Chen, Peter S. Dragovich, Matthew Volgraf, Matthew R. Wright, Jian Payandeh, Claudio Ciferri, and John C. Tellis
- Abstract
The voltage-gated sodium (NaV) channel NaV1.7 has been identified as a potential novel pain target due to its striking human genetics. However, clinically available drugs (e.g. lidocaine, carbamazepine, etc.) are not selective among the nine NaV channel subtypes, NaV1.1-NaV1.9, and the two currently known classes of NaV1.7 subtype-selective inhibitors (aryl- and acylsulfonamides) have undesirable characteristics that may limit their development. Moreover, understanding of the structure-activity relationships of the acylsulfonamide class of NaV1.7 inhibitors, exemplified by the clinical development candidateGDC-0310, has been based solely on a single co-crystal structure of an arylsulfonamide inhibitor series. To advance inhibitor design targeting the NaV1.7 channel, we established an iterative system to routinely obtain high-resolution ligand-bound NaV1.7 structures using cryogenic electron microscopy (cryo-EM). We report thatGDC-0310engages the NaV1.7 voltage-sensing domain 4 (VSD4) through an unexpected binding mode orthogonal to the arylsulfonamide class binding pose, which identifies a previously unknown ligand binding site in NaV channels. This finding enabled the design of a novel hybrid inhibitor series that bridges the aryl and acylsulfonamide binding pockets and allows for the generation of molecules with substantially differentiated structures and properties. Overall, this study highlights the power of cryo-EM methods to pursue challenging drug targets using iterative and high-resolution structure-guided inhibitor design. It also underscores an important role of the membrane bilayer in the discovery of selective NaV channel modulators.
- Published
- 2022
- Full Text
- View/download PDF
7. Discovery of Acyl-sulfonamide Nav1.7 Inhibitors GDC-0276 and GDC-0310
- Author
-
Sultan Chowdhury, Christoph Martin Dehnhardt, Tao Sheng, Clint Young, Rainbow Kwan, Michael Scott Wilson, Jun Chen, Matthew Waldbrook, Dinah Misner, C. Lee Robinette, Rebecca M. Reese, Elaine Chang, Henry Verschoof, Tanja S. Zabka, Girish Bankar, Philippe Bergeron, Luis Sojo, Karen Nelkenbrecher, Daniel P. Sutherlin, Amy Kim, Ivan William Hemeon, Andrea Lindgren, Jae H. Chang, Alla Yurevna Zenova, Shaoyi Sun, Jonathan Maher, Shannon D. Shields, Jun Li, Daniel F. Ortwine, David H. Hackos, Zhiwei Xie, Thilo Focken, Charles J. Cohen, Richard T. Dean, Shannon Decker, Janette Mezeyova, Kuldip Khakh, Antonio G. DiPasquale, Chien-An Chen, Andrew D. White, Brian Safina, Jodie Pang, Qi Jia, Sophia Lin, Jean-Christophe Andrez, J. P. Johnson, and Steven J. McKerrall
- Subjects
0303 health sciences ,Chemistry ,Sulfonamide (medicine) ,Phase 1 trials ,Pharmacology ,Metabolic stability ,01 natural sciences ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,03 medical and health sciences ,Pharmacokinetics ,Drug Discovery ,NAV1 ,medicine ,Molecular Medicine ,Dosing ,030304 developmental biology ,medicine.drug - Abstract
Nav1.7 is an extensively investigated target for pain with a strong genetic link in humans, yet in spite of this effort, it remains challenging to identify efficacious, selective, and safe inhibitors. Here, we disclose the discovery and preclinical profile of GDC-0276 (1) and GDC-0310 (2), selective Nav1.7 inhibitors that have completed Phase 1 trials. Our initial search focused on close-in analogues to early compound 3. This resulted in the discovery of GDC-0276 (1), which possessed improved metabolic stability and an acceptable overall pharmacokinetics profile. To further derisk the predicted human pharmacokinetics and enable QD dosing, additional optimization of the scaffold was conducted, resulting in the discovery of a novel series of N-benzyl piperidine Nav1.7 inhibitors. Improvement of the metabolic stability by blocking the labile benzylic position led to the discovery of GDC-0310 (2), which possesses improved Nav selectivity and pharmacokinetic profile over 1.
- Published
- 2021
- Full Text
- View/download PDF
8. VIVA-uOttawa / CBSA at TRECVID 2012: Interactive Surveillance Event Detection.
- Author
-
Chris Whiten, Robert Laganière, Ehsan Fazl Ersi, Feng Shi, Guillaume-Alexandre Bilodeau, Dmitry O. Gorodnichy, Jean-Philippe Bergeron, Ehren Choy, and David Bissessar
- Published
- 2012
9. Endocytic proteins with prion-like domains form viscoelastic condensates that enable membrane remodeling
- Author
-
Louis-Philippe Bergeron-Sandoval, Sandeep Kumar, Hossein Khadivi Heris, Catherine L. A. Chang, Caitlin E. Cornell, Sarah L. Keller, Paul François, Adam G. Hendricks, Allen J. Ehrlicher, Rohit V. Pappu, and Stephen W. Michnick
- Subjects
0303 health sciences ,Multidisciplinary ,Saccharomyces cerevisiae Proteins ,Prions ,Protein Conformation ,Glutamine ,030302 biochemistry & molecular biology ,Cell Membrane ,Saccharomyces cerevisiae ,Viscoelastic Substances ,protein–protein interactions ,Biological Sciences ,Mechanotransduction, Cellular ,Endocytosis ,03 medical and health sciences ,Cytoskeletal Proteins ,Biophysics and Computational Biology ,Cytosol ,Gene Expression Regulation, Fungal ,biomolecular condensates ,viscoelasticity ,030304 developmental biology - Abstract
Significance The uptake of molecules into cells, known as endocytosis, requires membrane invagination and the formation of vesicles. A version of endocytosis that is independent of actin polymerization is aided by the assembly of membraneless biomolecular condensates at the site of membrane invagination. Here, we show that endocytic condensates are viscoelastic bodies that concentrate key proteins with prion-like domains to enable membrane remodeling. A distinct molecular grammar, namely the preference for glutamine versus asparagine residues, underlies the cohesive interactions that give rise to endocytic condensates. We incorporate material properties inferred using active rheology into a mechanical model to explain how cohesive interactions within condensates and interfacial tensions among condensates, membranes, and the cytosol can drive membrane invagination to initiate endocyosis., Membrane invagination and vesicle formation are key steps in endocytosis and cellular trafficking. Here, we show that endocytic coat proteins with prion-like domains (PLDs) form hemispherical puncta in the budding yeast, Saccharomyces cerevisiae. These puncta have the hallmarks of biomolecular condensates and organize proteins at the membrane for actin-dependent endocytosis. They also enable membrane remodeling to drive actin-independent endocytosis. The puncta, which we refer to as endocytic condensates, form and dissolve reversibly in response to changes in temperature and solution conditions. We find that endocytic condensates are organized around dynamic protein–protein interaction networks, which involve interactions among PLDs with high glutamine contents. The endocytic coat protein Sla1 is at the hub of the protein–protein interaction network. Using active rheology, we inferred the material properties of endocytic condensates. These experiments show that endocytic condensates are akin to viscoelastic materials. We use these characterizations to estimate the interfacial tension between endocytic condensates and their surroundings. We then adapt the physics of contact mechanics, specifically modifications of Hertz theory, to develop a quantitative framework for describing how interfacial tensions among condensates, the membrane, and the cytosol can deform the plasma membrane to enable actin-independent endocytosis.
- Published
- 2021
10. Ansatz zur Wirtschaftlichkeitsbewertung von Kleinwasserkraftanlagen in China
- Author
-
Felix Tettenborn, Philippe Bergeron, and Publica
- Subjects
Water Science and Technology - Abstract
Um die finanzielle Tragfähigkeit der Umsetzung eines verbesserten Kleinwasserkraftanlagendesigns hinsichtlich des chinesischen Elektrizitätsmarkts abzuschätzen zu können, wurde ein einfach umzusetzender Bewertungsansatz erstellt. Grundlage für diesen Ansatz war die Durchführung einer entsprechenden Bewertung für das Kleinwasserkraftwerk Shichang im Flussgebiet Chong'an in der Provinz Guizhou. Aus der beispielhaften Bewertung wurden Empfehlungen abgeleitet, die eine Fokussierung auf die relevanten Parameter erlauben und die anzustrebenden Bereiche der finanziellen Leistungsindikatoren aufzeigen.
- Published
- 2019
- Full Text
- View/download PDF
11. Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain
- Author
-
Jodie Pang, Lunbin Deng, Girish Bankar, Jun Chen, Sultan Chowdhury, William R Proctor, Philippe Bergeron, Jennifer Vogt, Daniel F. Ortwine, Daniel P. Sutherlin, Jian Payandeh, Lilia Schumann, Shannon D. Shields, Christoph Martin Dehnhardt, Jae H. Chang, David H. Hackos, Elisa Ballini, Teresa Nguyen, Pengfei Ji, Glauco Tarozzo, Charles J. Cohen, Antonio G. DiPasquale, Kwong Wah Lai, Jonathan Maher, Kuldip Khakh, Steven J. McKerrall, Tania Chernov-Rogan, Wenfeng Liu, Brian Safina, Sophia Lin, Abid Hasan, and J. P. Johnson
- Subjects
0303 health sciences ,Ligand efficiency ,Ligand ,Chemistry ,Stereochemistry ,Mutagenesis ,01 natural sciences ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,03 medical and health sciences ,chemistry.chemical_compound ,In vivo ,Drug Discovery ,Lipophilicity ,Molecular Medicine ,Structure–activity relationship ,Chromane ,Binding site ,030304 developmental biology - Abstract
Using structure- and ligand-based design principles, a novel series of piperidyl chromane arylsulfonamide Nav1.7 inhibitors was discovered. Early optimization focused on improvement of potency through refinement of the low energy ligand conformation and mitigation of high in vivo clearance. An in vitro hepatotoxicity hazard was identified and resolved through optimization of lipophilicity and lipophilic ligand efficiency to arrive at GNE-616 (24), a highly potent, metabolically stable, subtype selective inhibitor of Nav1.7. Compound 24 showed a robust PK/PD response in a Nav1.7-dependent mouse model, and site-directed mutagenesis was used to identify residues critical for the isoform selectivity profile of 24.
- Published
- 2019
- Full Text
- View/download PDF
12. Discovery of Acyl-sulfonamide Na
- Author
-
Brian S, Safina, Steven J, McKerrall, Shaoyi, Sun, Chien-An, Chen, Sultan, Chowdhury, Qi, Jia, Jun, Li, Alla Y, Zenova, Jean-Christophe, Andrez, Girish, Bankar, Philippe, Bergeron, Jae H, Chang, Elaine, Chang, Jun, Chen, Richard, Dean, Shannon M, Decker, Antonio, DiPasquale, Thilo, Focken, Ivan, Hemeon, Kuldip, Khakh, Amy, Kim, Rainbow, Kwan, Andrea, Lindgren, Sophia, Lin, Jonathan, Maher, Janette, Mezeyova, Dinah, Misner, Karen, Nelkenbrecher, Jodie, Pang, Rebecca, Reese, Shannon D, Shields, Luis, Sojo, Tao, Sheng, Henry, Verschoof, Matthew, Waldbrook, Michael S, Wilson, Zhiwei, Xie, Clint, Young, Tanja S, Zabka, David H, Hackos, Daniel F, Ortwine, Andrew D, White, J P, Johnson, C Lee, Robinette, Christoph M, Dehnhardt, Charles J, Cohen, and Daniel P, Sutherlin
- Subjects
Rats, Sprague-Dawley ,Voltage-Gated Sodium Channel Blockers ,Sulfonamides ,HEK293 Cells ,Piperidines ,Benzamides ,Drug Discovery ,NAV1.7 Voltage-Gated Sodium Channel ,Animals ,Azetidines ,Humans ,Cells, Cultured - Abstract
Na
- Published
- 2021
13. genèse, berceau, dessin de la lune
- Author
-
Jean-Philippe Bergeron and Jean-Philippe Bergeron
- Abstract
Septième livre de Jean-Philippe Bergeron (Grand prix Québecor du FIPTR 2019), genèse, berceau, dessin de la lune explore « la bifurcation existentielle » que la naissance d'un enfant peut opérer en nous ; ce que le poète nomme « l'effondrement/en moi/du moi ». Déployé en trois parties dont la temporalité évoque celle des rêves, le recueil s'ancre dans la « coexistence/entre être/et non être » pour déployer, autour de la naissance et au-delà, une phénoménologie de l'apparition. L'enfant, ici, jaillit d'un corps, d'un nom, et pourtant nous sommes loin de la poésie conceptuelle, car au fil des pages le rythme même des poèmes s'attache à calquer sa respiration : « je remplace/un à un/mes organes/par tes premières/pensées », peut-on lire, à mesure que s'incarne l'existence dans ce qu'elle a de plus brut et d'inattendu. Recueil d'un grand bouleversement, genèse, berceau, dessin de la lune traduit magnifiquement les « secousses du monde intérieur ».
- Published
- 2023
14. Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Na
- Author
-
Steven J, McKerrall, Teresa, Nguyen, Kwong Wah, Lai, Philippe, Bergeron, Lunbin, Deng, Antonio, DiPasquale, Jae H, Chang, Jun, Chen, Tania, Chernov-Rogan, David H, Hackos, Jonathan, Maher, Daniel F, Ortwine, Jodie, Pang, Jian, Payandeh, William R, Proctor, Shannon D, Shields, Jennifer, Vogt, Pengfei, Ji, Wenfeng, Liu, Elisa, Ballini, Lilia, Schumann, Glauco, Tarozzo, Girish, Bankar, Sultan, Chowdhury, Abid, Hasan, J P, Johnson, Kuldip, Khakh, Sophia, Lin, Charles J, Cohen, Christoph M, Dehnhardt, Brian S, Safina, and Daniel P, Sutherlin
- Subjects
Male ,Voltage-Gated Sodium Channel Blockers ,Analgesics ,Sulfonamides ,Binding Sites ,Cell Survival ,NAV1.7 Voltage-Gated Sodium Channel ,Ligands ,Cell Line ,Rats ,Molecular Docking Simulation ,Mice ,Structure-Activity Relationship ,Dogs ,Mutagenesis, Site-Directed ,Animals ,Humans ,Protein Isoforms ,Chronic Pain ,Half-Life - Abstract
Using structure- and ligand-based design principles, a novel series of piperidyl chromane arylsulfonamide Na
- Published
- 2019
15. Mechanisms and Consequences of Macromolecular Phase Separation
- Author
-
Nozhat Safaee, Stephen W. Michnick, and Louis-Philippe Bergeron-Sandoval
- Subjects
Organelles ,0301 basic medicine ,Cytoplasm ,Molecular interactions ,Proteins ,Physiology ,Computational biology ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Cellular protein ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Dequalinium ,Protein Interaction Mapping ,Animals ,Humans ,Colloids ,030217 neurology & neurosurgery - Abstract
Over a century ago, colloidal phase separation of matter into non-membranous bodies was recognized as a fundamental organizing principal of cell "protoplasm." Recent insights into the molecular properties of such phase-separated bodies present challenges to our understanding of cellular protein interaction networks, as well as opportunities for interpreting and understanding of native and pathological genetic and molecular interactions. Here, we briefly review examples of and discuss physical principles of phase-separated cellular bodies and then reflect on how knowledge of these principles may direct future research on their functions.
- Published
- 2016
- Full Text
- View/download PDF
16. Dynamic FLNa and FilGAP Binding Is Required for Contractile Mechanotransduction Response to Shear-Stress
- Author
-
Louis-Philippe Bergeron-Sandoval and Allen J. Ehrlicher
- Subjects
Chemistry ,Biophysics ,Shear stress ,FLNA ,Mechanotransduction - Published
- 2021
- Full Text
- View/download PDF
17. Mechanics, Structure and Function of Biopolymer Condensates
- Author
-
Stephen W. Michnick and Louis-Philippe Bergeron-Sandoval
- Subjects
Condensed Matter::Quantum Gases ,0301 basic medicine ,Work (thermodynamics) ,Materials science ,Biochemical Phenomena ,Proteins ,engineering.material ,Structure and function ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Biopolymers ,Structural Biology ,Chemical physics ,Intermolecular interaction ,engineering ,Animals ,Humans ,Thermodynamics ,Biopolymer ,Molecular Biology ,030217 neurology & neurosurgery - Abstract
The spontaneous nature of biopolymer phase separation in cells entails that the resulting condensates can be thermodynamic machines, which, in the process of condensing, can take on distinct forms themselves and deform neighboring cellular structures. We introduce here general notions of material and mechanical properties of protein condensates with an emphasis on how molecular arrangements and intermolecular interaction within condensates determine their ability to do work on their surroundings. We further propose functional implications of these concepts to cellular and subcellular morphology and biogenesis.
- Published
- 2018
18. Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells
- Author
-
Ron Firestein, Philippe Bergeron, E.V. Schneider, Maureen Beresini, Jiansheng Wu, Laurent Salphati, Kevin R Clark, James R. Kiefer, Mark McCleland, Klaus Maskos, Linda Orren, Krista K. Bowman, Elizabeth Blackwood, Michael F. T. Koehler, and Steve Schmidt
- Subjects
0301 basic medicine ,Kinase ,Organic Chemistry ,Biology ,Biochemistry ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Cell culture ,030220 oncology & carcinogenesis ,Drug Discovery ,Cyclin-dependent kinase complex ,Cyclin-dependent kinase 8 ,Phosphorylation ,Efflux ,Kinase activity ,Cyclin - Abstract
Beginning with promiscuous COT inhibitors, which were found to inhibit CDK8, a series of 6-aza-benzothiophene containing compounds were developed into potent, selective CDK8 inhibitors. When cocrystallized with CDK8 and cyclin C, these compounds exhibit an unusual binding mode, making a single hydrogen bond to the hinge residue A100, a second to K252, and a key cation-π interaction with R356. Structure-based drug design resulted in tool compounds 13 and 32, which are highly potent, kinase selective, permeable compounds with a free fraction >2% and no measurable efflux. Despite these attractive properties, these compounds exhibit weak antiproliferative activity in the HCT-116 colon cancer cell line. Further examination of the activity of 32 in this cell line revealed that the compound reduced phosphorylation of the known CDK8 substrate STAT1 in a manner identical to a CDK8 knockout clone, illustrating the complex effects of inhibition of CDK8 kinase activity in proliferation in these cells.
- Published
- 2016
- Full Text
- View/download PDF
19. Mechanical Energy of Protein Phase Separation Shapes Cell Membranes
- Author
-
Louis-Philippe Bergeron-Sandoval, Stephen W. Michnick, Hossein K. Heris, Allen J. Ehrlicher, Paul François, Rohit V. Pappu, and Adam G. Hendricks
- Subjects
Cytosol ,Membrane ,medicine.anatomical_structure ,Polymerization ,Chemistry ,Cell ,medicine ,Biophysics ,Endocytosis ,Actin ,Intracellular ,Membrane invagination - Abstract
Clathrin-mediated endocytosis (CME) underlies intra- and extracellular material trafficking in eukaryotes, and is essential to protein metabolism, intercellular signaling, membrane remodeling and other cell regulatory processes. Although CME is usually driven by F-actin polymerization, membrane invagination can also occur through actin independent mechanisms. Here, we show that viscoelastic protein condensates that form via liquid-liquid phase separation at the sites of endocytosis initiation facilitate actin independent CME. Binding energies of the condensate with the membrane and surrounding cytosol provides work required to drive membrane invagination. Our findings expand the repertoire of functions associated with protein condensates that form via liquid-liquid phase separation to include their ability to do work at soft interfaces, thus shaping and organizing cellular matter.
- Published
- 2018
- Full Text
- View/download PDF
20. A Cell-Signaling Network Temporally Resolves Specific versus Promiscuous Phosphorylation
- Author
-
S. Sinan Isik, Louis-Philippe Bergeron-Sandoval, Stephen W. Michnick, Evgeny Kanshin, and Pierre Thibault
- Subjects
Glycerol ,Phosphopeptides ,Proteomics ,Cell signaling ,Saccharomyces cerevisiae ,Biology ,Microtubules ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,Tandem Mass Spectrometry ,Phosphorylation ,lcsh:QH301-705.5 ,Chromatography, High Pressure Liquid ,030304 developmental biology ,0303 health sciences ,Kinase ,Osmolar Concentration ,Phosphoproteomics ,biology.organism_classification ,Actins ,Phosphoric Monoester Hydrolases ,Cell biology ,Spindle apparatus ,Biochemistry ,lcsh:Biology (General) ,Signal transduction ,Protein Kinases ,030217 neurology & neurosurgery ,Signal Transduction - Abstract
SummaryIf specific and functional kinase- or phosphatase-substrate interactions are optimized for binding compared to promiscuous interactions, then changes in phosphorylation should occur faster on functional versus promiscuous substrates. To test this hypothesis, we designed a high temporal resolution global phosphoproteomics protocol to study the high-osmolarity glycerol (HOG) response in the budding yeast Saccharomyces cerevisiae. The method provides accurate, stimulus-specific measurement of phosphoproteome changes, quantitative analysis of phosphodynamics at sub-minute temporal resolution, and detection of more phosphosites. Rates of evolution of dynamic phosphosites were comparable to those of known functional phosphosites and significantly lower than static or longer-time-frame dynamic phosphosites. Kinetic profile analyses indicated that putatively functional kinase- or phosphatase-substrate interactions occur more rapidly, within 60 s, than promiscuous interactions. Finally, we report many changes in phosphorylation of proteins implicated in cytoskeletal and mitotic spindle dynamics that may underlie regulation of cell cycle and morphogenesis.
- Published
- 2015
21. L’INTÉGRATION SOCIOPROFESSIONNELLE DES PERSONNES EN SITUATION D’ITINÉRANCE
- Author
-
Yves Hallée, Mustapha Bettache, and Philippe Bergeron
- Published
- 2017
- Full Text
- View/download PDF
22. Proteins with prion-like domains can form viscoelastic condensates that enable membrane remodeling and endocytosis
- Author
-
Adam G. Hendricks, Allen J. Ehrlicher, Stephen W. Michnick, Sandeep Kumar, Catherine Chang, Sarah L. Keller, Caitlin E. Cornell, Paul François, Louis-Philippe Bergeron-Sandoval, Rohit V. Pappu, and Hossein K. Heris
- Subjects
0303 health sciences ,03 medical and health sciences ,Cytosol ,Membrane ,Vesicle ,030302 biochemistry & molecular biology ,Endocytic cycle ,Biophysics ,Endocytosis ,Viscoelasticity ,Actin ,030304 developmental biology ,Membrane invagination - Abstract
SummaryMembrane invagination and vesicle formation are key steps in endocytosis and cellular trafficking. Here, we show that endocytic coat proteins with prion-like domains (PLDs) form hemispherical puncta in the budding yeast, S. cerevisiae. These puncta have the hallmarks of biomolecular condensates and enable membrane remodeling to drive actin-independent endocytosis. The puncta, which we refer to as endocytic condensates, form and dissolve reversibly in response to changes in temperature and solution conditions. The condensates are organized around dynamic protein-protein interaction networks, which involve interactions among PLDs with high glutamine contents. The endocytic coat protein Sla1 is at the hub of the protein-protein interaction network. Using active rheology, we indirectly characterized the material properties of endocytic condensates. These experiments show that endocytic condensates are viscoelastic materials and allow us to estimate the interfacial tension between endocytic condensates and their surroundings. We then adapt the physics of contact mechanics, specifically the contact theory of Hertz, to develop a quantitative framework for describing how interfacial tensions among condensates, the membrane, and the cytosol can deform the plasma membrane to enable actin independent endocytosis.
- Published
- 2017
- Full Text
- View/download PDF
23. A Practical Synthesis of a Potent and Selective Diacylglycerol Acyltransferase-1 (DGAT-1) Inhibitor
- Author
-
Lawrence R. McGee, Philippe Bergeron, Youngsook Shin, Timothy D. Cushing, Frank Kayser, Brian M. Fox, Marc Labelle, Sharon McKendry, and Dustin McMinn
- Subjects
Organic Chemistry ,Regioselectivity ,Enol ,Combinatorial chemistry ,Catalysis ,Acylation ,chemistry.chemical_compound ,chemistry ,Organic chemistry ,Stereoselectivity ,Knoevenagel condensation ,Trifluoromethanesulfonate ,Friedel–Crafts reaction ,Diacylglycerol kinase - Abstract
A practical synthesis of a potent, selective, and orally efficacious diacylglycerol acyltransferase-1 (DGAT-1) inhibitor, is described. This synthesis is suitable for multi-kilogram scale with high regioselectivity and stereoselectivity. The synthesis involves a Knoevenagel condensation with Meldrum’s acid followed by the stereoselective addition of phenyl cuprate, regioselective Friedel–Crafts acylation, cyclization, and a regioselective reduction through an enol triflate with catalytic platinum oxide to provide the desired compound in 5.2% yield over 12 steps.
- Published
- 2014
- Full Text
- View/download PDF
24. Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 Mutations
- Author
-
Arna Katewa, Daniel F. Ortwine, Pawan Bir Kohli, James J. Crawford, Christine Tam, Regina Choy, Yvonne Franke, Jiansheng Wu, Hong Li, Luciana Burton, Adam R. Johnson, Emily B. Gogol, Charles Eigenbrot, Kyle Mortara, Lisa D. Belmont, Elicia Penuel, Philippe Bergeron, Wendy B. Young, Alberto Estevez, May Lin, Christine Yu, and Krista K. Bowman
- Subjects
0301 basic medicine ,Threonine ,Mutant ,Antineoplastic Agents ,medicine.disease_cause ,Biochemistry ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Piperidines ,immune system diseases ,hemic and lymphatic diseases ,medicine ,Agammaglobulinaemia Tyrosine Kinase ,Bruton's tyrosine kinase ,Humans ,Cysteine ,Binding site ,Protein Kinase Inhibitors ,chemistry.chemical_classification ,Mutation ,biology ,Adenine ,General Medicine ,Protein-Tyrosine Kinases ,Leukemia, Lymphocytic, Chronic, B-Cell ,Kinetics ,030104 developmental biology ,Enzyme ,Pyrimidines ,chemistry ,030220 oncology & carcinogenesis ,Ibrutinib ,biology.protein ,Cancer research ,Molecular Medicine ,Pyrazoles ,Signal transduction ,Tyrosine kinase - Abstract
The Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has shown impressive clinical efficacy in a range of B-cell malignancies. However, acquired resistance has emerged, and second generation therapies are now being sought. Ibrutinib is a covalent, irreversible inhibitor that modifies Cys481 in the ATP binding site of Btk and renders the enzyme inactive, thereby blocking B-cell receptor signal transduction. Not surprisingly, Cys481 is the most commonly mutated Btk residue in cases of acquired resistance to ibrutinib. Mutations at other sites, including Thr474, a gatekeeper residue, have also been detected. Herein, we describe noncovalent Btk inhibitors that differ from covalent inhibitors like ibrutinib in that they do not interact with Cys481, they potently inhibit the ibrutinib-resistant Btk C481S mutant in vitro and in cells, and they are exquisitely selective for Btk. Noncovalent inhibitors such as GNE-431 also show excellent potency against the C481R, T474I, and T474M mutants. X-ray crystallographic analysis of Btk provides insight into the unique mode of binding of these inhibitors that explains their high selectivity for Btk and their retained activity against mutant forms of Btk. This class of noncovalent Btk inhibitors may provide a treatment option to patients, especially those who have acquired resistance to ibrutinib by mutation of Cys481 or Thr474.
- Published
- 2016
25. Potent, Selective, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin Kinase Domain Exhibiting Single Agent Antiproliferative Activity
- Author
-
Lichuan Liu, Leslie Lee, Jennifer Epler, Kevin Lau, Jim Nonomiya, Daniel F. Ortwine, Elizabeth Blackwood, Tom Truong, Xiao Ding, Steve Sideris, Joseph P. Lyssikatos, Cuong Ly, Lan Trinh, Deepak Sampath, Gauri Deshmukh, Jason Oeh, Yung-Hsiang Chen, Jiansheng Wu, Philippe Bergeron, Zhonghua Pei, Shiva Malek, Krista K. Bowman, and Michael F. T. Koehler
- Subjects
Male ,Transplantation, Heterologous ,Administration, Oral ,Biological Availability ,Mice, Nude ,Antineoplastic Agents ,Mechanistic Target of Rapamycin Complex 2 ,mTORC1 ,Mechanistic Target of Rapamycin Complex 1 ,Pharmacology ,mTORC2 ,Mice ,Structure-Activity Relationship ,In vivo ,Cell Line, Tumor ,Drug Discovery ,Animals ,Humans ,Pyrroles ,Phosphorylation ,PI3K/AKT/mTOR pathway ,Phosphoinositide-3 Kinase Inhibitors ,Chemistry ,Kinase ,TOR Serine-Threonine Kinases ,Prostatic Neoplasms ,Molecular Docking Simulation ,Pyrimidines ,Biochemistry ,Protein kinase domain ,Multiprotein Complexes ,Quinazolines ,Molecular Medicine ,Female ,Drug Screening Assays, Antitumor ,Neoplasm Transplantation - Abstract
Selective inhibitors of mammalian target of rapamycin (mTOR) kinase based upon saturated heterocycles fused to a pyrimidine core were designed and synthesized. Each series produced compounds with K(i)10 nM for the mTOR kinase and500-fold selectivity over closely related PI3 kinases. This potency translated into strong pathway inhibition, as measured by phosphorylation of mTOR substrate proteins and antiproliferative activity in cell lines with a constitutively active PI3K pathway. Two compounds exhibiting suitable mouse PK were profiled in in vivo tumor models and were shown to suppress mTORC1 and mTORC2 signaling for over 12 h when dosed orally. Both compounds were additionally shown to suppress tumor growth in vivo in a PC3 prostate cancer model over a 14 day study.
- Published
- 2012
- Full Text
- View/download PDF
26. Access to Saturated Fused Pyrimidine Derivatives via a Flexible N-Vinyl Tertiary Enamide Synthesis
- Author
-
Philippe Bergeron, Frédéric St-Jean, Anthony A. Estrada, and Joseph P. Lyssikatos
- Subjects
Bicyclic molecule ,Chemistry ,Organic Chemistry ,Organic chemistry - Published
- 2011
- Full Text
- View/download PDF
27. Potent, Selective, and Orally Bioavailable Inhibitors of Mammalian Target of Rapamycin (mTOR) Kinase Based on a Quaternary Substituted Dihydrofuropyrimidine
- Author
-
Antonio G. DiPasquale, Daniel F. Ortwine, Lan Trinh, Frederick Cohen, Cuong Ly, Kevin Lau, Lichuan Liu, Tom Truong, Elizabeth Blackwood, Cristina Lewis, Kirk Robarge, Steve Sideris, Jiansheng Wu, Joseph P. Lyssikatos, Jennifer Epler, Zhonghua Pei, Philippe Bergeron, Xianrui Zhao, Krista K. Bowman, Michael F. T. Koehler, Jim Nonomiya, Huifen Chen, and Shiva Malek
- Subjects
Models, Molecular ,Transplantation, Heterologous ,Administration, Oral ,Biological Availability ,Mice, Nude ,Antineoplastic Agents ,Pharmacology ,Mice ,Structure-Activity Relationship ,Drug Stability ,Species Specificity ,Cell Line, Tumor ,Drug Discovery ,medicine ,Animals ,Humans ,Furans ,PI3K/AKT/mTOR pathway ,Phosphoinositide-3 Kinase Inhibitors ,Chemistry ,Kinase ,TOR Serine-Threonine Kinases ,Cancer ,Stereoisomerism ,medicine.disease ,Rats ,Bioavailability ,Pyrimidines ,Biochemistry ,Molecular Medicine ,Drug Screening Assays, Antitumor ,PI3 Kinases ,Neoplasm Transplantation - Abstract
A series of inhibitors of mTOR kinase based on a quaternary-substituted dihydrofuropyrimidine was designed and synthesized. The most potent compounds in this series inhibited mTOR kinase with K(i)1.0 nM and were highly (100×) selective for mTOR over the closely related PI3 kinases. Compounds in this series showed inhibition of the pathway and antiproliferative activity in cell-based assays. Furthermore, these compounds had excellent mouse PK, and showed a robust PK-PD relationship in a mouse model of cancer.
- Published
- 2011
- Full Text
- View/download PDF
28. Fiabilité test retest et validité de construit de la version française de L'Échelle fonctionnelle des membres inférieurs (ÉFMI), partie II
- Author
-
Lynn Casimiro, Megan Silva, Louis-Philippe Bergeron, Victoria Stockwell, Phanny Chea, Liliane Létourneau, Lucie Brosseau, Manon Tremblay, and Frédéric René
- Subjects
Canada ,Surveys and Questionnaires ,Humans ,Reproducibility of Results ,Physical Therapy, Sports Therapy and Rehabilitation ,Articles ,Factor Analysis, Statistical ,Language - Abstract
RÉSUMÉ Introduction : Le Lower Extremity Functional Scale a été traduit en français en 2006. La version canadienne-française se nomme l'Échelle fonctionnelle des membres inférieurs (ÉFMI). La validité de construit et la fiabilité test-retest de l'ÉFMI n'ont pas encore été examinées. But : Examiner la fiabilité test-retest, la consistance interne et la validité de construit de l'ÉFMI. Méthodologie : Trente-quatre participants ayant subi une chirurgie ou une blessure à un membre inférieur ont rempli un questionnaire démographique et complété l'ÉFMI lors d'une évaluation initiale alors qu'ils étaient hospitalisés. Ils ont à nouveau complété l'ÉFMI dans un intervalle de 72 heures après la première évaluation. Le coefficient de corrélation intra-classe (CCI) et le coefficient kappa ont été utilisés afin d'examiner la fiabilité de type test-retest de l'ÉFMI. Le coefficient alpha Cronbach a été calculé pour évaluer la consistance interne. L'analyse factorielle a été utilisée pour examiner la validité de construit afin de déterminer le nombre de dimensions et leur signification respective. Résultats : Le CCI s'élève à une valeur de 0,92 [0,88–0,96] (IC: 95%). Le résultat du test α-Cronbach est de 0,95 (0,91–0,99) IC à 95%. L'analyse factorielle révèle que tous les éléments de l'ÉFMI se logent sur une dimension principale. Conclusion : Les résultats montrent que la version canadienne-française de l'ÉFMI est un outil unidimensionnel qui offre une fiabilité test-retest et une consistance interne excellentes.
- Published
- 2011
- Full Text
- View/download PDF
29. Une version canadienne française du Lower Extremity Functional Scale (LEFS) : L'Échelle fonctionnelle des membres inférieurs (ÉFMI), partie I
- Author
-
Véronik Belliveau, Louis-Philippe Bergeron, Lynn Casimiro, Annabelle Lefebvre, Lucie Brosseau, Martine Beaudouin, Manon Tremblay, and Frédéric René
- Subjects
Canada ,Surveys and Questionnaires ,Reproducibility of Results ,Translations ,Physical Therapy, Sports Therapy and Rehabilitation ,Articles ,Translating - Abstract
RÉSUMÉ Introduction : Le Rehabilitation Network of Ottawa-Carleton (RENOC) recommande à ses établissements de santé d'utiliser le Lower Extremity Functional Scale (LEFS). Puisque le RENOC dessert une clientèle anglophone et francophone, il s'imposait de traduire le LEFS pour l'évaluation de la clientèle francophone. But : Produire une traduction canadienne-française du LEFS sous l'appellation proposée « Échelle fonctionnelle des membres inférieurs (ÉFMI) » et examiner la validité de son contenu. Méthodologie : Nous avons utilisé une approche modifiée de la méthodologie de validation transculturelle de questionnaires de Vallerand (1989). Une traduction renversée parallèle du LEFS a d'abord été complétée. Ensuite, un comité d'experts a examiné les deux versions préliminaires et a créé la première version expérimentale de l'ÉFMI. Cette version fut évaluée par un deuxième comité d'experts, dont les commentaires menèrent à une deuxième version expérimentale. Finalement, 35 professionnels de la réadaptation évaluèrent la version expérimentale de l'ÉFMI sur une échelle d'ambiguïté et proposèrent les modifications finales. Résultats : Pour les différents énoncés de la version finale de l'ÉFMI, les moyennes sur l'échelle d'ambiguïté démontrent un niveau d'ambiguïté relativement faible puisqu'elles varient entre 1 et 2.54. Conclusion : Les quatre étapes rigoureuses du processus ont permis de produire une version valide du LEFS en français.
- Published
- 2011
- Full Text
- View/download PDF
30. A Protein Condensate Drives Actin-Independent Endocytosis
- Author
-
Paul François, Louis-Philippe Bergeron-Sandoval, Rohit V. Pappu, Allen J. Ehrlicher, Hossein K. Heris, Adam G. Hendricks, and Stephen W. Michnick
- Subjects
Chemistry ,Biophysics ,A protein ,Endocytosis ,Actin ,Cell biology - Published
- 2019
- Full Text
- View/download PDF
31. Production of Human Rotavirus and Salmonella Antigens in Plants and Elicitation of fljB-Specific Humoral Responses in Mice
- Author
-
Aurélie Girard, Denis Archambault, Fathey Sarhan, François Ouellet, and Louis-Philippe Bergeron-Sandoval
- Subjects
Rotavirus ,Salmonella ,Recombinant Fusion Proteins ,viruses ,Protein subunit ,Nicotiana benthamiana ,Bioengineering ,medicine.disease_cause ,Applied Microbiology and Biotechnology ,Biochemistry ,Microbiology ,law.invention ,Mice ,Antigen ,law ,Tobacco ,medicine ,Animals ,Humans ,Antigens, Viral ,Molecular Biology ,Pathogen ,Cells, Cultured ,Antigens, Bacterial ,Mice, Inbred BALB C ,biology ,fungi ,virus diseases ,food and beverages ,biology.organism_classification ,Immunity, Humoral ,biology.protein ,Recombinant DNA ,Capsid Proteins ,Female ,Rabbits ,Antibody ,Flagellin ,Biotechnology - Abstract
A Nicotiana benthamiana transient expression system was used to express single antigen and dimeric combinations of the human rotavirus (HRV) VP7 and a truncated VP4 (VP4Δ) proteins fused with Salmonella typhimurium's flagellin fljB subunit. Immunoblot analyses using rabbit antibodies generated against these proteins demonstrated that the constructs were successfully expressed with yields ranging from 0.85 to 31.97 μg of recombinant protein per gram of fresh leaf tissue. Expressing the single and dimeric antigens has no effect on plant growth and development except for VP7 and VP4Δ::VP7, which show mild necrotic lesions. Immunization of mice with proteins from leaves transformed with constructs bearing the fljB moiety elicited an fljB-specific humoral response. The Nicotiana benthamiana transient system is efficient to express multiple combinations of pathogen proteins and demonstrates the potential of generating a Salmonella typhimurium subunit vaccine in plants.
- Published
- 2010
- Full Text
- View/download PDF
32. Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8
- Author
-
Elizabeth Blackwood, Linda Orren, Klaus Maskos, Mark McCleland, Sreemathy Ramaswamy, Laurent Salphati, Jiansheng Wu, James R. Kiefer, Maureen Beresini, Ron Firestein, Steve Schmidt, E.V. Schneider, Philippe Bergeron, Krista K. Bowman, Michael F. T. Koehler, and Kevin R Clark
- Subjects
0301 basic medicine ,Sorafenib ,Stereochemistry ,Organic Chemistry ,Biology ,Biochemistry ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Drug Discovery ,medicine ,Cyclin-dependent kinase 8 ,Cyclin ,medicine.drug - Abstract
Using Sorafenib as a starting point, a series of potent and selective inhibitors of CDK8 was developed. When cocrystallized with CDK8 and cyclin C, these compounds exhibit a Type-II (DMG-out) binding mode.
- Published
- 2016
33. La promotion des droits de la personne influe-t-elle sur l’évolution des plaintes portant sur le devoir syndical de juste représentation au Québec ? (1978-2005)
- Author
-
Philippe Bergeron and Marie-Josée Legault
- Subjects
General Materials Science - Abstract
Contrepartie du monopole de représentation syndicale, le devoir de juste représentation s’impose aux syndicats du Québec en vertu du Code du travail depuis 1978. Parallèlement, à la faveur de la promulgation des lois et des chartes des droits de la personne au Québec depuis les années 70, la promotion des droits de la personne fait craindre à certains observateurs les effets interactifs de deux ensembles juridiques très différents (droits de la personne et droit des rapports collectifs de travail) et, entre autres, l’effet perturbateur d’une logique dite d’intérêts individuels. Les auteurs étudient ici empiriquement l’évolution du recours pour manquement au devoir de juste représentation en faisant une revue de toutes les décisions rendues en vertu de l’article 47.3 du Code du travail. S’ils ne peuvent constater que les recours fondés sur une condition protégée par les lois sur les droits de la personne augmentent, en revanche, la jurisprudence en matière de devoir de juste représentation amène les auteurs à s’interroger quant à la faible protection de la norme d’égalité dans le champ du droit au travail que permet l’application de l’article 47.3. L’arrêt Parry Sound rendu en 2003 pourrait cependant changer la donne., As a counter-balance to trade unions’ representative monopoly, Québec unions have since 1978 been held answerable to the duty of even-handed representation. Likewise, owing to the enactment of Québec human rights statutes and charters since the 1970s, the promotion of human rights has led some observers to fear the interactive effects of two very different fields of legal intervention (human rights and group relationships based upon Labour Law), and also, the disruptive effects of logical reasonings centred on individual interests. As such, the authors empirically delve into the evolution of recourses for neglect of one’s duty for providing even-handed representation by reviewing all the rulings handed down under subsection 47.3 of the Labour Code. While they fall short of observing that recourses based upon a condition protected by human rights legislation are increasing, they nonetheless note that precedents regarding the duty to even-handed representation have led them to question the weak protection afforded to the standard of equality in the field of labour law that permits the enforcement of subsection 47.3. The Parry Sound decision handed down in 2003 could, however, usher in the era of a reverse trend.
- Published
- 2005
- Full Text
- View/download PDF
34. A General Version of Crow's Shadow Volumes.
- Author
-
Philippe Bergeron 0001
- Published
- 1986
- Full Text
- View/download PDF
35. L’intégration socioprofessionnelle des personnes en situation d’itinérance : état de la question et proposition d’un modèle conceptualisé à partir de l’institutionnalisme pragmatiste de John Rogers Commons
- Author
-
Philippe Bergeron, Mustapha Bettache, and Yves Hallée
- Subjects
Marketing ,Pharmacology ,Organizational Behavior and Human Resource Management ,itinérance ,lcsh:HB71-74 ,pragmatist institutionalism ,Strategy and Management ,lcsh:Economics as a science ,Pharmaceutical Science ,path ,réseau ,lcsh:Economic history and conditions ,socio-occupational integration ,parcours ,Drug Discovery ,network ,lcsh:HC10-1085 ,Sociology ,intégration socioprofessionnelle ,Humanities ,institutionnalisme pragmatiste ,homelessness - Abstract
Ce texte propose un modèle théorique permettant l’analyse d’expériences d’intégration socioprofessionnelle de personnes en situation d’itinérance. Ce modèle idéal type est construit à partir des études qui traitent du parcours de la personne itinérante et des organismes d’aide en réseau. S’intéressant à la fois à l’individu et à la structuration de l’action collective qui se déploie afin de favoriser l’intégration socioprofessionnelle, les auteurs proposent ensuite une conceptualisation du modèle à partir de l’institutionnalisme pragmatiste de J.R. Commons. This paper presents a theoretical model designed to study cases of socio-occupational integration involving homeless people. This ideal-type model is based on studies related to the career path followed by homeless people and to helping agencies that work together in a network. Dealing at the same time with the individual and with the structuring of collective action in order to facilitate socio-occupational integration, the authors then propose a conceptualization of the model based on J. R. Commons’ concept of pragmatist institutionalism.
- Published
- 2014
36. Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL
- Author
-
Brad E. Sleebs, Philippe Bergeron, Jonathan B. Baell, Wilhelmus J A Kersten, Zhi-Fu Tao, Lisa A. Hasvold, Paul Gibbons, Keith G. Watson, Michael F. T. Koehler, Wayne J. Fairbrother, Carl S. Rye, Sanjitha Kulasegaram, Guillaume Lessene, Chinh T. Bui, Brian J. Smith, Peter M. Colman, Le Wang, Edna F. Choo, Danette Dudley, Steven W. Elmore, David C.S. Huang, Chudi Ndubaku, Kevin Lau, Peter E. Czabotar, John A. Flygare, Andrew J. Souers, and George Nikolakopoulos
- Subjects
chemistry.chemical_classification ,Navitoclax ,biology ,business.industry ,Chronic lymphocytic leukemia ,In silico ,Organic Chemistry ,Hydrazone ,Bcl-xL ,medicine.disease ,Bioinformatics ,Biochemistry ,Lymphoma ,chemistry.chemical_compound ,chemistry ,immune system diseases ,Apoptosis ,hemic and lymphatic diseases ,Drug Discovery ,biology.protein ,Cancer research ,medicine ,Potency ,business - Abstract
Because of the promise of BCL-2 antagonists in combating chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL), interest in additional selective antagonists of antiapoptotic proteins has grown. Beginning with a series of selective, potent BCL-XL antagonists containing an undesirable hydrazone functionality, in silico design and X-ray crystallography were utilized to develop alternative scaffolds that retained the selectivity and potency of the starting compounds.
- Published
- 2014
37. A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors
- Author
-
Joseph P. Lyssikatos, Shiva Malek, Philippe Bergeron, Jim Nonomiya, Kirk Robarge, Daniel F. Ortwine, Kevin Lau, Lichuan Lin, Wendy Lee, Steve Sideris, Zhonghua Pei, and Stephen Schmidt
- Subjects
Models, Molecular ,Pyrimidine ,Stereochemistry ,Clinical Biochemistry ,Substituent ,Pharmaceutical Science ,Biochemistry ,chemistry.chemical_compound ,Structure-Activity Relationship ,Drug Discovery ,Humans ,Molecular Biology ,Protein Kinase Inhibitors ,PI3K/AKT/mTOR pathway ,Dose-Response Relationship, Drug ,Molecular Structure ,Kinase ,TOR Serine-Threonine Kinases ,Organic Chemistry ,Hit to lead ,Discovery and development of mTOR inhibitors ,Pyrimidines ,chemistry ,Molecular Medicine ,PI3 Kinases ,Selectivity - Abstract
A series of N-7-methyl-imidazolopyrimidine inhibitors of the mTOR kinase have been designed and prepared, based on the hypothesis that the N-7-methyl substituent on imidazolopyrimidine would impart selectivity for mTOR over the related PI3Kα and δ kinases. The corresponding N-Me substituted pyrrolo[3,2-d]pyrimidines and pyrazolo[4,3-d]pyrimidines also show potent mTOR inhibition with selectivity toward both PI3α and δ kinases. The most potent compound synthesized is pyrazolo[4,3-d]pyrimidine 21c. Compound 21c shows a Ki of 2 nM against mTOR inhibition, remarkable selectivity (>2900×) over PI3 kinases, and excellent potency in cell-based assays.
- Published
- 2013
38. Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2
- Author
-
Kathy Barrett, Paul Gibbons, Steven Shia, Jane R. Kenny, Mark Zak, Charles Ellwood, Sharada Labadie, Richard James Bull, Chris Hamman, Peter H. Crackett, Peter Gribling, Peter S. Dragovich, Scott Savage, Jiangpeng Liao, Jason DeVoss, Christine Chang, Paroma Chakravarty, Mercedesz Balazs, Wyne P. Lee, Tony Johnson, Rebecca Pulk, Michael F. T. Koehler, Gauri Deshmukh, Marya Liimatta, Janusz J. Kulagowski, Pawan Bir Kohli, Anne van Abbema, Austin John Reeve, Rohan Mendonca, Adam R. Johnson, Ignacio Aliagas, Simon Gaines, Charles Eigenbrot, Yisong Xiao, Nico Ghilardi, Jing Yang, Christopher A. Hurley, Philippe Bergeron, Wade S. Blair, Peter Hewitt, Stuart Ward, Eric Harstad, Micah Steffek, Barbara Avitabile-Woo, Stefan Gradl, Raman Narukulla, and Savita Ubhayakar
- Subjects
Models, Molecular ,Cell Membrane Permeability ,Membrane permeability ,Stereochemistry ,Pyridines ,Administration, Oral ,Biological Availability ,Stereoisomerism ,Crystallography, X-Ray ,Protein–protein interaction ,Madin Darby Canine Kidney Cells ,Dogs ,Drug Discovery ,Moiety ,Animals ,Humans ,Pyrroles ,Whole blood ,Molecular Structure ,Chemistry ,Imidazoles ,Haplorhini ,Janus Kinase 1 ,Janus Kinase 2 ,Ligand (biochemistry) ,Arthritis, Experimental ,Bioavailability ,Rats ,Isoenzymes ,Antirheumatic Agents ,Microsomes, Liver ,Molecular Medicine ,Collagen ,Selectivity ,Heterocyclic Compounds, 3-Ring - Abstract
Herein we report on the structure-based discovery of a C-2 hydroxyethyl moiety which provided consistently high levels of selectivity for JAK1 over JAK2 to the imidazopyrrolopyridine series of JAK1 inhibitors. X-ray structures of a C-2 hydroxyethyl analogue in complex with both JAK1 and JAK2 revealed differential ligand/protein interactions between the two isoforms and offered an explanation for the observed selectivity. Analysis of historical data from related molecules was used to develop a set of physicochemical compound design parameters to impart desirable properties such as acceptable membrane permeability, potent whole blood activity, and a high degree of metabolic stability. This work culminated in the identification of a highly JAK1 selective compound (31) exhibiting favorable oral bioavailability across a range of preclinical species and robust efficacy in a rat CIA model.
- Published
- 2013
39. Some Useful but Rather Unusual Graphical Primitives.
- Author
-
Nadia Magnenat-Thalmann, Daniel Thalmann, and Philippe Bergeron 0001
- Published
- 1981
- Full Text
- View/download PDF
40. Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349
- Author
-
Elizabeth Blackwood, Yung-Hsiang Chen, Frederick Cohen, Jim Nonomiya, Gauri Deshmukh, Suzanne Tay, Ulka Vijapurkar, Joseph P. Lyssikatos, Marcia Belvin, Jennifer Epler, Xianrui Zhao, Sophie Mukadam, Lan Trinh, Huifen Chen, Linda Bao, Philippe Bergeron, Xiao Ding, Michael F. T. Koehler, Shiva Malek, Jane R. Kenny, Steve Sideris, Tom Truong, Daniel F. Ortwine, Anthony A. Estrada, John Lesnick, Zhonghua Pei, Cuong Ly, Kevin Lau, Lichuan Liu, and Lori Friedman
- Subjects
business.industry ,Kinase ,Organic Chemistry ,Tumor cells ,Pharmacology ,Discovery and development of mTOR inhibitors ,Biochemistry ,Mouse xenograft ,Drug Discovery ,Cancer research ,Medicine ,Signal transduction ,business ,PI3K/AKT/mTOR pathway - Abstract
Aberrant activation of the PI3K-Akt-mTOR signaling pathway has been observed in human tumors and tumor cell lines, indicating that these protein kinases may be attractive therapeutic targets for treating cancer. Optimization of advanced lead 1 culminated in the discovery of clinical development candidate 8h, GDC-0349, a potent and selective ATP-competitive inhibitor of mTOR. GDC-0349 demonstrates pathway modulation and dose-dependent efficacy in mouse xenograft cancer models.
- Published
- 2012
41. Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2
- Author
-
Paul Gibbons, Wade S. Blair, Sharada Labadie, Janusz J. Kulagowski, Adam R. Johnson, Kathy Barrett, Savita Ubhayakar, Patrick J. Lupardus, Christopher A. Hurley, Philippe Bergeron, Steven Shia, Stuart Ward, Charles Eigenbrot, Gauri Deshmukh, Anne van Abbema, Jeremy Murray, Mark Ultsch, Peter S. Dragovich, Mark Zak, Marya Liimatta, Rebecca Pulk, Pawan Bir Kohli, Nico Ghilardi, Rohan Mendonca, Jane R. Kenny, Christine Chang, and Micah Steffek
- Subjects
Male ,Models, Molecular ,Stereochemistry ,Pyridines ,Clinical Biochemistry ,Pharmaceutical Science ,Crystallography, X-Ray ,Biochemistry ,Rats, Sprague-Dawley ,Structure-Activity Relationship ,Drug Discovery ,Structure–activity relationship ,Molecule ,Animals ,Humans ,Pyrroles ,Amino acid residue ,Molecular Biology ,Protein Kinase Inhibitors ,chemistry.chemical_classification ,Dose-Response Relationship, Drug ,Molecular Structure ,Drug discovery ,Organic Chemistry ,Imidazoles ,Janus Kinase 1 ,Janus Kinase 2 ,Rats ,Sprague dawley ,Enzyme ,chemistry ,Molecular Medicine ,Structure based ,Selectivity - Abstract
Herein we describe our successful efforts in obtaining C-2 substituted imidazo-pyrrolopyridines with improved JAK1 selectivity relative to JAK2 by targeting an amino acid residue that differs between the two isoforms (JAK1: E966; JAK2: D939). Efforts to improve cellular potency by reducing the polarity of the inhibitors are also detailed. The X-ray crystal structure of a representative inhibitor in complex with the JAK1 enzyme is also disclosed.
- Published
- 2012
42. Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2
- Author
-
Philippe Bergeron, Sharada Labadie, Nico Ghilardi, Jeremy Murray, Stuart Ward, Charles Eigenbrot, Pawan Bir Kohli, Scott Savage, Ling Xiao, Janusz J. Kulagowski, Wade S. Blair, Micah Steffek, Tony Johnson, Gauri Deshmukh, Emily J. Hanan, Chris Hamman, Mark Zak, Jiangpeng Liao, Michael F. T. Koehler, Kathy Barrett, Madeleine Rodriguez, Robert James Maxey, Jason DeVoss, Peter S. Dragovich, Rebecca Pulk, Steven Shia, Mark Ultsch, Rohan Mendonca, Anne van Abbema, Yisong Xiao, Zhonghua Lin, Patrick J. Lupardus, Tian Jin, Adam R. Johnson, Stefan Gradl, Christopher A. Hurley, Paul Gibbons, Jane R. Kenny, Marya Liimatta, Savita Ubhayakar, Eric Harstad, Christine Chang, Mercedesz Balazs, and Peter Hewitt
- Subjects
Models, Molecular ,Stereochemistry ,Biological Availability ,Crystallography, X-Ray ,Cell Line ,Mice ,Structure-Activity Relationship ,Dogs ,In vivo ,Drug Discovery ,Structure–activity relationship ,Potency ,Bioassay ,Animals ,Humans ,ADME ,Chemistry ,Janus Kinase 1 ,Janus Kinase 2 ,In vitro ,Bioavailability ,Rats ,Hepatocytes ,Molecular Medicine ,Biological Assay ,Selectivity ,Heterocyclic Compounds, 3-Ring - Abstract
Herein we report the discovery of the C-2 methyl substituted imidazopyrrolopyridine series and its optimization to provide potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2. The C-2 methyl substituted inhibitor 4 exhibited not only improved JAK1 potency relative to unsubstituted compound 3 but also notable JAK1 vs JAK2 selectivity (20-fold and >33-fold in biochemical and cell-based assays, respectively). Features of the X-ray structures of 4 in complex with both JAK1 and JAK2 are delineated. Efforts to improve the in vitro and in vivo ADME properties of 4 while maintaining JAK1 selectivity are described, culminating in the discovery of a highly optimized and balanced inhibitor (20). Details of the biological characterization of 20 are disclosed including JAK1 vs JAK2 selectivity levels, preclinical in vivo PK profiles, performance in an in vivo JAK1-mediated PK/PD model, and attributes of an X-ray structure in complex with JAK1.
- Published
- 2012
43. ChemInform Abstract: Access to Saturated Fused Pyrimidine Derivatives via a Flexible N-Vinyl Tertiary Enamide Synthesis
- Author
-
Philippe Bergeron, Anthony A. Estrada, Frédéric St-Jean, and Joseph P. Lyssikatos
- Subjects
chemistry.chemical_compound ,Pyrimidine ,Chemistry ,Microwave irradiation ,Organic chemistry ,General Medicine ,Combinatorial chemistry - Abstract
Protection by the -Pmb group is crucial for a successful transformation which needs neither microwave irradiation nor reflux conditions.
- Published
- 2011
- Full Text
- View/download PDF
44. Flagellin produced in plants is a potent adjuvant for oral immunization
- Author
-
Fathey Sarhan, Denis Archambault, Louis-Philippe Bergeron-Sandoval, Aurélie Girard, and Wilfried A. A. Saron
- Subjects
Salmonella typhimurium ,Salmonella ,Ovalbumin ,medicine.medical_treatment ,Nicotiana benthamiana ,Administration, Oral ,Biology ,medicine.disease_cause ,Antibodies ,Microbiology ,Mice ,Adjuvants, Immunologic ,Tobacco ,medicine ,Animals ,Technology, Pharmaceutical ,Mice, Inbred BALB C ,General Veterinary ,General Immunology and Microbiology ,fungi ,Fresh weight ,Public Health, Environmental and Occupational Health ,food and beverages ,biology.organism_classification ,Plants, Genetically Modified ,Virology ,Recombinant Proteins ,Immunoglobulin A ,Oral immunization ,Infectious Diseases ,Immunoglobulin G ,Vaccines, Subunit ,biology.protein ,Molecular Medicine ,Female ,Adjuvant ,Flagellin - Abstract
The aim of this study was to produce adjuvant with high biosafety, efficacy and low cost. Towards this goal, the plant Nicotiana benthamiana transient expression system was successfully used to express Salmonella typhimurium's flagellin (FljB). The yield of the expressed FljB was 280 mg per kg of fresh weight (FW) leaves. The lyophilized plant powder containing plant expressing FljB was mixed with ovalbumin (OVA) and used for oral immunization of BALB/c mice. The ELISA analysis showed higher and accelerated OVA-specific serum antibody responses in mice given the mixture when compared to animals receiving OVA alone. Furthermore, FljB elicited a mixed Th1/Th2 response as shown by the presence of specific anti-OVA IgG1, IgG2a and IgG2b isotypes. OVA-specific IgAs were also detected in mice given the mixture. Cell-mediated immune response to OVA was induced by FljB as determined by a spleen lymphocyte specific proliferation test. No immune response was generated against FljB. In conclusion, our results showed for the first time the production of FljB in plants and the efficient use of the crude lyophilized extract as an adjuvant for oral immunization.
- Published
- 2011
45. Antagonists of inhibitor of apoptosis proteins based on thiazole amide isosteres
- Author
-
Vickie Tsui, Philippe Bergeron, Kevin Lau, Stephen F. Keteltas, John A. Flygare, Linda O. Elliott, Cuong Ly, Frederick Cohen, Wayne J. Fairbrother, Michael F. T. Koehler, Lewis J. Gazzard, and Matthew C. Franklin
- Subjects
Models, Molecular ,Stereochemistry ,Peptidomimetic ,Clinical Biochemistry ,Pharmaceutical Science ,Inhibitor of apoptosis ,Crystallography, X-Ray ,Biochemistry ,Protein–protein interaction ,Inhibitor of Apoptosis Proteins ,chemistry.chemical_compound ,Biomimetics ,Amide ,Drug Discovery ,Humans ,Binding site ,Thiazole ,Molecular Biology ,Binding Sites ,Organic Chemistry ,Amides ,Thiazoles ,chemistry ,Benzothiazole ,Molecular Medicine ,Peptides ,Fluorescence anisotropy - Abstract
A series of IAP antagonists based on thiazole or benzothiazole amide isosteres was designed and synthesized. These compounds were tested for binding to the XIAP-BIR3 and ML-IAP BIR using a fluorescence polarization assay. The most potent of these compounds, 19a and 33b, were found to have K(i)'s of 20-30 nM against ML-IAP and 50-60 nM against XIAP-BIR3.
- Published
- 2010
46. Erratum to 'Antagonists of inhibitor of apoptosis proteins based on thiazole amide isosteres' [Bioorg. Med. Chem. Lett. 20 (2010) 2229–2233]
- Author
-
Stephen F. Keteltas, Lewis J. Gazzard, Matthew C. Franklin, Vickie Tsui, Linda O. Elliott, Philippe Bergeron, Frederick Cohen, Cuong Ly, Michael F. T. Koehler, Wayne J. Fairbrother, Kevin Lau, and John A. Flygare
- Subjects
chemistry.chemical_compound ,chemistry ,Stereochemistry ,Amide ,Organic Chemistry ,Clinical Biochemistry ,Drug Discovery ,Pharmaceutical Science ,Molecular Medicine ,Inhibitor of apoptosis ,Thiazole ,Molecular Biology ,Biochemistry - Published
- 2012
- Full Text
- View/download PDF
47. L’intégration socioprofessionnelle des personnes en situation d’itinérance : état de la question et proposition d’un modèle conceptualisé à partir de l’institutionnalisme pragmatiste de John Rogers Commons
- Author
-
Yves Hallée, Mustapha Bettache, and Philippe Bergeron
- Subjects
homelessness ,socio-occupational integration ,network ,path ,pragmatist institutionalism ,Economic history and conditions ,HC10-1085 ,Economics as a science ,HB71-74 - Abstract
This paper presents a theoretical model designed to study cases of socio-occupational integration involving homeless people. This ideal-type model is based on studies related to the career path followed by homeless people and to helping agencies that work together in a network. Dealing at the same time with the individual and with the structuring of collective action in order to facilitate socio-occupational integration, the authors then propose a conceptualization of the model based on J. R. Commons’ concept of pragmatist institutionalism.
- Full Text
- View/download PDF
48. A computer graphical tool for analyzing user reaction to video‐tex systems
- Author
-
Philippe Bergeron, Nadia Magnenat-Thalmann, and Daniel Thalmann
- Subjects
Computer graphics ,Multimedia ,Computer science ,Human–computer interaction ,Evaluation methods ,General Engineering ,Information system ,Videotex ,Graphics ,User interface ,computer.software_genre ,computer - Abstract
The INVIDO system is a graphical tool which was designed and implemented for studying user reactions to videotex systems. For different themes, including weather reporting, sport results and winning numbers in lotteries, different visual presentations have been created. As home visual information systems will invade the market in the next few years, it is essential to develop new tools which can give an idea of the user's reaction to this kind of information. The entire methodology (graphics capabilities, implementation and investigation) is presented. Numerous examples are also given.
- Published
- 1982
- Full Text
- View/download PDF
49. C) De nouveaux moyens
- Author
-
Philippe Bergeron and Richard Perusse
- Published
- 1987
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.